1201 Camino de Salud, NE MSC07 4025 UNMCC Administration Building, Albuquerque, NM 87131
Website: University of New Mexico Comprehensive Cancer Center
Contact:
Rebecca Myers-Brito
505-925-0355
Linked In
You Tube
University of New Mexico Comprehensive Cancer Center
Trials at this location:
HCRN-GU20-444
Neoadjuvant Pembrolizumab for Muscle-Invasive Bladder Cancer with Selective Bladder Sparing
Status: Open to Accrual
HCRN-GU14-188
Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-Ineligible) in Subjects With T2-4aN0M0 Urothelial Cancer: HCRN GU14-188
Status: Closed to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter